CSI Market
Sign In | Register

Gyre Therapeutics Inc (GYRE) Quarterly Balance Sheets

Quarterly · GAAP · USD millions
Access GYRE Annual Balance Sheets →
Balance sheet patterns shown here provide context for understanding Gyre Therapeutics Inc's financial stability and long-term positioning.
View historic periods: Download as CSV:
Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.
Quarterly Report, GAAP in USD millions
ITEM 		(Jun 30 2026)
(Mar 31 2026) (Dec 31 2025) (Sep 30 2025) (Jun 30 2025)
Assets
Cash & cash equivalent43.29
Cash, Cash Equivalents Other0.50
Short-term Investments, Total42.50
Cash & Short-term Investments85.00
Accounts receivable27.99
Other Receivables, Net, Current0.01
Notes, Loans and Financing Receivable, Net, Current AC0.23
Inventories11.43
Other Current Assets0.00
Prepaid Expense And Other Assets Current8.00
Total Current Assets122.07
Equipment/Property/Plant Net39.98
Intangible Assets4.53
Long-term investments1.60
Deferred, Prepaid and Other Assets, Noncurrent0.30
Other Assets, Noncurrent18.90
Prepaid Assets Current-
Operating Lease Right Of Use Asset-
Total Assets199.26
Liabilities
Accounts Payable, Current AC18.81
Accrued Liabilities And Other Liabilities0.00
Other Liabilities, Current0.00
Accrued Income Taxes, Current TA2.15
Total Current Liabilities28.66
Total Long-term Debt0.00
Derivative Liability, Noncurrent DE2.74
Deferred Revenue, Noncurrent DE0.83
Other liabilities, Noncurrent9.81
Contract With Customer Liability Current0.75
Operating Lease Liability Noncurrent0.07
Total Liabilities34.34
Stockholders' Equity
Statutory Reserve3.65
Common Stock Value0.11
Additional Paid In Capital Common Stock240.64
Retained Earnings / Accumulated Deficit-137.96
Accumulated Other Comprehensive Income1.49
Other Equity1.49
Common Stockholder's Equity107.93
Non-controlling interests & other34.56
Total Stockholder's Equity142.49
Liabilities & Stockholder's Equity199.26
4 historic quarters locked

Sign in to unlock the full Gyre Therapeutics Inc balance sheet history.

Sign In Create Free Account

About Gyre Therapeutics Inc Quarterly Balance Sheet

What this statement shows

This page presents issuer-reported balance sheet data, detailing assets, liabilities, and stockholders equity as reported in SEC 10-Q filings and standardized by CSIMarket. The balance sheet reflects the company's financial position at the end of each reporting period.

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - balance-sheet normalization in the CSIMarket.com financial database.
  • Accession: 0001193125-26-340448

Balance sheet figures represent financial position at specific reporting dates and may be revised in subsequent filings.